Market Analysis and Insights: Global Viral Molecular Diagnostics Market
Molecular diagnostics refers to a technique used to detect and identify the presence of genetic material or proteins associated with a specific health condition or disease.
The global Viral Molecular Diagnostics market size is projected to reach US$ 13090 million by 2030, from US$ 8000 million in 2022, at a CAGR of 7.2% during 2023-2030.
North America, followed by Europe, has the largest market for viral molecular diagnostics due to developed healthcare infrastructure, accessibility and affordability of diagnostic tests for viral infectious diseases in this region.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Viral Molecular Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Viral Molecular Diagnostics market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Viral Molecular Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Viral Molecular Diagnostics market.
Global Viral Molecular Diagnostics Scope and Market Size
Viral Molecular Diagnostics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Viral Molecular Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2030.
Segment by Type
Hepatitis B Virus (HBV)
Hepatitis C Virus (HCV)
Human Immunodeficiency Virus (HIV)
Human Papillomavirus (HPV)
Segment by Application
Hospitals
Academics Institutions
Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Laboraories
Bio-Rad Laboratories
Becton, Dickinson
Roche
Gen-Probe
Qiagen
Olympus
Thermo Fisher Scientific
